Bioequivalence for Parenteral Products [Regulatives / Guidelines]

posted by arailkar – 2020-05-29 15:21 (119 d 08:00 ago) – Posting: # 21491
Views: 782

Dear Helmut,

I am interested in finding out if bioequivalence study is needed in the US when an IV formulation is changed to a subcutaneous formulation. I would also appreciate if you can please give me references to US FDA Guidance document that addresses this topic. Thank you very much.


Complete thread:

 Admin contact
21,076 posts in 4,394 threads, 1,468 registered users;
online 7 (0 registered, 7 guests [including 2 identified bots]).
Forum time: Friday 23:21 UTC (Europe/Vienna)

For every fact
there is an infinity of hypotheses.    Robert M. Pirsig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz